Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant | The BMJ

Generating your feed, please be patient ...

Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant | The BMJ | Zootzle